Deniz Tural

14PUBLICATIONS
53CO-AUTHORS
Cell physiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 22, 2026
The Clinical Significance of Gallium-68 PSMA-11 PET-Derived SUVmax in the Management of Metastatic Hormone-Sensitive Prostate Cancer.

|Sep 02, 2025
Very deep prostate-specific antigen decline is associated with longer rPFS in patients with metastatic castration-sensitive prostate cancer.

Caner Kapar, Ilkay Gulturk, Volkan Tugcu

|May 20, 2025
Prognostic Importance of PTEN and P53 in Aggressive Luminal A Subtype Breast Cancers.

Öykü Dila Gemci, Serdar Altınay, İlkay Gültürk

|Apr 13, 2024
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

Mahmut Emre Yildirim, Nuri Karadurmuş, İlker Nihat Ökten

|Apr 04, 2024
Change in the neutrophil-lymphocyte ratio may predict early recurrence in operated bladder cancer.

Rumeysa Çolak, Gökmen Umut Erdem, Caner Kapar

|Jun 23, 2022
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.

Mutlu Hizal, Burak Bilgin, Nail Paksoy

Pageof 3

Frequent Collaborators

4 joint publications

Ilkay Gulturk

3 joint publications

Seher Yıldız Tacar

2 joint publications

Mutlu Hızal

2 joint publications

Mesut Yilmaz